Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 111 | 0.370 |
Why?
|
| Paclitaxel | 1 | 2012 | 143 | 0.370 |
Why?
|
| Macular Edema | 1 | 2012 | 94 | 0.350 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 555 | 0.280 |
Why?
|
| Uveitis | 1 | 2013 | 38 | 0.100 |
Why?
|
| Albumin-Bound Paclitaxel | 1 | 2012 | 3 | 0.100 |
Why?
|
| Albumins | 1 | 2012 | 99 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 509 | 0.100 |
Why?
|
| Bevacizumab | 1 | 2012 | 80 | 0.100 |
Why?
|
| Intravitreal Injections | 1 | 2012 | 153 | 0.090 |
Why?
|
| Visual Acuity | 2 | 2013 | 713 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 224 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 572 | 0.070 |
Why?
|
| Conjunctiva | 1 | 2007 | 194 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2007 | 536 | 0.060 |
Why?
|
| Dry Eye Syndromes | 1 | 2007 | 284 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2003 | 97 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 2762 | 0.040 |
Why?
|
| HIV Infections | 1 | 2013 | 2075 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2003 | 433 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2003 | 899 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 872 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2013 | 17568 | 0.030 |
Why?
|
| Aged | 2 | 2013 | 21497 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 13103 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 2145 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 237 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 313 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2013 | 401 | 0.020 |
Why?
|
| Female | 3 | 2013 | 71482 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2013 | 824 | 0.020 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2007 | 19 | 0.020 |
Why?
|
| CD4-CD8 Ratio | 1 | 2007 | 13 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 103 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 253 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 235 | 0.020 |
Why?
|
| Metaplasia | 1 | 2007 | 178 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2007 | 154 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2007 | 106 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2007 | 240 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 366 | 0.020 |
Why?
|
| Tears | 1 | 2007 | 176 | 0.020 |
Why?
|
| Humans | 3 | 2013 | 133331 | 0.010 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 2003 | 8 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1433 | 0.010 |
Why?
|
| Metribolone | 1 | 2003 | 31 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 28 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2003 | 25 | 0.010 |
Why?
|
| Testosterone Congeners | 1 | 2003 | 19 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 906 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2003 | 62 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2003 | 37 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2003 | 65 | 0.010 |
Why?
|
| Mifepristone | 1 | 2003 | 138 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2003 | 55 | 0.010 |
Why?
|
| Receptors, Calcitriol | 1 | 2003 | 73 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 286 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 6544 | 0.010 |
Why?
|
| Prostatic Hyperplasia | 1 | 2003 | 118 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 2575 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 839 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 787 | 0.010 |
Why?
|
| Prostate | 1 | 2003 | 448 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1378 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1612 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 1420 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3979 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9920 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 10951 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 788 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 4823 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 1341 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 2125 | 0.010 |
Why?
|
| Animals | 2 | 2007 | 36217 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 28977 | 0.010 |
Why?
|
| Male | 2 | 2013 | 65576 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 31674 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 18936 | 0.000 |
Why?
|